A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries

CompletedOBSERVATIONAL
Enrollment

291

Participants

Timeline

Start Date

December 13, 2016

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions
Arterial Occlusive DiseasesAtherosclerosisVascular DiseasesArteriosclerosis
Interventions
DEVICE

Peripheral stenting

stent implantation during the index procedure

Trial Locations (23)

3300

Regionaal Ziekenhuis Heilig Hart Tienen, Tienen

3600

ZOL Genk, Genk

10004

Hospital San Pedro de Alcántara, Cáceres

14100

ASL Asti, Asti

19002

Hosp . Universitario de Guadalajara, Guadalajara

28006

Hosp. Ntra Sra. del Rosario, Madrid

28040

Hospital Clinico San Carlos, Madrid

30071

Hospital de Montecelo (Pontevedra EOXI), Pontevedra

50009

Foundation for the Aragonese Healthcare Research Institute, Zaragoza

53100

Hospital Azienda Ospedaliera Universitaria Senese, Siena

78150

Clinique Parly II, Le Chesnay

Unknown

Medizinische Universität Graz, Graz

CHU Sart Tilman, Liège

Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble

Policlinico Vittorio Emanuele, Catania

Policlinico di Monza, Monza

IRCCS Policlinico San Donato, San Donato Milanese

Hosp. Puerta del Mar, Cadiz

Hosp. Complejo Hosp Universitario (CHUO), Ourense

Hospital Parc Tauli, Sabadell

00161

Policlinico Umberto I, Roma

00193

L'Azienda sanitaira ASL Roma 1, Roma

09006

Hospital Universitario de Burgos, Burgos

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY

NCT03037411 - A Real World Evaluation of the ELUVIA Stent in Subjects With Lesions Located in the Femoropopliteal Arteries | Biotech Hunter | Biotech Hunter